Alpha 2.0
Login Register
» Articles » PMID: 15944244

Agonist Activity of the Small Molecule C3aR Ligand SB 290157

Overview
Journal J Immunol
Specialty Allergy & Immunology
Date 2005 Jun 10
PMID 15944244
Citations 7
Authors
Alex G Therien
Affiliations
Soon will be listed here.
Citing Articles

Cntnap4 partial deficiency exacerbates α-synuclein pathology through astrocyte-microglia C3-C3aR pathway.

Zhang W, Ding L, Chen H, Zhang M, Ma R, Zheng S Cell Death Dis. 2023; 14(4):285.

PMID: 37087484 PMC: 10122675. DOI: 10.1038/s41419-023-05807-y.

C3a receptor antagonist therapy is protective with or without thrombolysis in murine thromboembolic stroke.

Ahmad S, Pandya C, Kindelin A, Bhatia K, Chaudhary R, Dwivedi A Br J Pharmacol. 2020; 177(11):2466-2477.

PMID: 31975437 PMC: 7205805. DOI: 10.1111/bph.14989.

Intracortical Administration of the Complement C3 Receptor Antagonist Trifluoroacetate Modulates Microglia Reaction after Brain Injury.

Surugiu R, Catalin B, Dumbrava D, Gresita A, Olaru D, Hermann D Neural Plast. 2019; 2019:1071036.

PMID: 31814819 PMC: 6877989. DOI: 10.1155/2019/1071036.

The Role of Complement C3a Receptor in Stroke.

Ahmad S, Bhatia K, Kindelin A, Ducruet A Neuromolecular Med. 2019; 21(4):467-473.

PMID: 31102134 DOI: 10.1007/s12017-019-08545-7.

The role of the complement system in traumatic brain injury: a review.

Hammad A, Westacott L, Zaben M J Neuroinflammation. 2018; 15(1):24.

PMID: 29357880 PMC: 5778697. DOI: 10.1186/s12974-018-1066-z.